Q3 EPS Forecast for Baxter International Reduced by Analyst

Baxter International Inc. (NYSE:BAX) – Equities research analysts at Zacks Research cut their Q3 2028 earnings per share (EPS) estimates for Baxter International in a report released on Monday, September 28th. Zacks Research analyst Team now forecasts that the medical instruments supplier will earn $0.54 per share for the quarter, down from their prior forecast of $0.55. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Baxter International’s current full-year earnings is $2.04 per share.

Several other research analysts have also recently issued reports on the stock. Stifel Nicolaus raised their target price on shares of Baxter International from $19.00 to $24.00 and gave the stock a “hold” rating in a report on Tuesday, July 28th. Wells Fargo & Company raised their price target on shares of Baxter International from $19.00 to $23.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Wall Street Zen upgraded shares of Baxter International from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. UBS Group upped their price objective on shares of Baxter International from $19.00 to $25.00 and gave the company a “hold” rating in a research note on Tuesday, July 28th. Finally, The Goldman Sachs Group raised their target price on Baxter International from $19.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. Two investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $22.45.

Baxter International Trading Down 1.6%

Shares of BAX opened at $23.62 on Friday. The firm has a market cap of $12.21 billion, a price-to-earnings ratio of -11.41, a PEG ratio of 3.63 and a beta of 0.66. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.32 and a current ratio of 1.95. Baxter International has a fifty-two week low of $15.73 and a fifty-two week high of $30.00. The firm has a 50 day moving average price of $25.30 and a 200-day moving average price of $21.29.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.19. The firm had revenue of $2.96 billion during the quarter, compared to analyst estimates of $2.80 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.The company’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.59 earnings per share. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS.

Institutional Trading of Baxter International

A number of hedge funds and other institutional investors have recently modified their holdings of BAX. Core Capital Management & Research inc. purchased a new position in Baxter International during the 2nd quarter valued at about $202,000. Tidal Investments LLC grew its holdings in Baxter International by 22.8% in the second quarter. Tidal Investments LLC now owns 164,400 shares of the medical instruments supplier’s stock worth $3,505,000 after purchasing an additional 30,510 shares during the period. Cidel Asset Management Inc. increased its holdings in shares of Baxter International by 15.9% during the second quarter. Cidel Asset Management Inc. now owns 12,143 shares of the medical instruments supplier’s stock valued at $259,000 after acquiring an additional 1,663 shares in the last quarter. Integrated Wealth Concepts LLC bought a new position in Baxter International in the 2nd quarter worth about $161,000. Finally, Community Bank N.A. bought a new stake in Baxter International during the 2nd quarter valued at about $46,000. 90.19% of the stock is owned by hedge funds and other institutional investors.

Baxter International Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Friday, August 28th were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Friday, August 28th. Baxter International’s payout ratio is -1.93%.

Baxter International News Roundup

Here are the key news stories impacting Baxter International this week:

• Positive Sentiment: Baxter released its inaugural Connected Hospital Report, highlighting the potential for connected medical technologies to improve hospital efficiency, patient care and clinical decision-making. The report may strengthen Baxter’s strategic positioning in digital and connected healthcare, although it does not provide a material near-term financial update. Baxter Releases Inaugural Connected Hospital Report

Baxter International Company Profile

Baxter International Inc is a global healthcare company that develops and markets products used in hospitals, outpatient facilities and other care settings. Its portfolio includes intravenous solutions and administration sets, infusion pumps, parenteral nutrition products, injectable medicines, surgical products and systems for medication preparation and delivery.

The company also provides products and technologies that support anesthesia, critical care, patient monitoring and other hospital workflows.